학술논문
Prognostic value of EndoPredict test in patients screened for UNIRAD, a UCBG randomized, double blind, phase III international trial evaluating the addition of everolimus (EVE) to adjuvant hormone therapy (HT) in women with high risk HR+, HER2-early breast cancer (eBC)
Document Type
Journal
Author
Penault-Llorca, Frederique; Dalenc, Florence; Chabaud, Sylvie; Cottu, Paul; Allouache, Djelila; Cameron, David; Jacquin, Jean-Philippe; Grenier, Julien; Bouvet, Laurence Venat; Jegannathen, Apurna; Campone, Mario; Del Piano, Francesco; Debled, Marc; Hardy-Bessard, Anne-Claire; Giacchetti, Sylvie; Barthelemy, Philippe; Kaluzinski, Laure; Mailliez, Audrey; Mouret-Reynier, Marie-Ange; Legouffe, Eric; Cayre, Anne; Martinez, Mathilde; Delbaldo, Catherine; Mollon-Grange, Delphine; Macaskill, E. Jane; Sephton, Matthew; Stefani, Laetitia; Belgadi, Blaha; Winter, Matthew; Orfeuvre, Hubert; Lacroix-Triki, Magali; Bonnefoi, Herve; Bliss, Judith; Canon, Jean-Luc; Lemonnier, Jerome; Andre, Fabrice; Bachelot, Thomas
Source
Subject
Language
English
ISSN
15387445